
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
Here: succinct highlights from new studies may offer you insights about multiple sclerosis you didn't have before.
MS and cigarettes; statins and secondary progressive MS; transitioning from Tysabri in JC+ recipients; cerebrospinal venous insufficiency and MS; and marijuana for MS symptoms. . . Here: key points from 5 new studies that you might have missed.





